The line is open for Cervera Technology Transfer R&D projects at CDTI 2023

Through the new Cervera 2023 call, CDTI will grant grants of up to 90% of the total approved budget.

Through the new Cervera 2023 call, CDTI will grant grants of up to 90% of the total approved budget.

Objective of the 2023 call

Strengthen the innovation capabilities by contracting R&D activities to knowledge-generating centers or collaborating with them for the development of R&D projects.

Beneficiaries

SMEs and MIDCAPS.

Type of aid

The Cervera 2023 call will grant partially repayable loans of up to 90% of the total budget approved by CDTI, with the following characteristics:

  • Interest rate: Fixed. 1-year Euribor (fixed at the time of approval of the aid).

* If the R&D project is co-financed with community funds, the interest rate will only apply to the refundable tranche of the aid.

  • Return period: 10 or 15 years.
  • Amortization: Biannual.
  • Advance payment: 35% of the aid with a limit of 250,000€, without the need for additional guarantees.

The non-refundable tranche may reach up to 33%, calculated on 75% of the budget. The beneficiary company may request the reasoned report once the loan agreement with the CDTI has been formalized.

Main requirements

  • Projects must have a minimum fundable budget of 175,000€ and a duration of between 12 and 36 months.
  • Projects may have one or more technical milestones, whose duration should be between 9 and 18 months.
  • Knowledge centers must have a minimum participation of 10% of the total approved budget.
  • Projects must be developed in a limited group of technological areas (Cervera* priority technologies).

*Cervera's priority technologies are defined as:

  • Advanced materials
  • Circular economy
  • Energy transition
  • Smart manufacturing
  • Technologies for health
  • Safe and healthy food chain
  • Deep Learning and Artificial Intelligence
  • Advanced mobile networks
  • Intelligent transport
  • Information protection
  • Quantum computing.

Fundable projects

Projects of research and business development of an applied nature for the creation or significant improvement of a productive process, product or service. Projects may include industrial research and experimental development activities and must demonstrate a differential technological aspect over existing technologies in the market.

Financiable expenses

  • Personnel expenses- Instrument and material costs
  • Contract research costs
  • Knowledge and acquired patents
  • Consulting and equivalent services (excluding those associated with the project request)
  • Additional overhead costs
  • Other expenses derived from the project

External collaborations may not exceed 65% of the eligible budget in general. In projects in the pharmaceutical sector, these expenses may reach up to 80% of the eligible budget.

Criteria for evaluating applications

At the technical level:

  • Plan for commercial exploitation of the project
  • Project Technology and Innovation
  • Capacity of the company in relation to the project
  • Socio-economic impact assessment, gender perspective and sustainability

At the financial level:

  • Analysis of the consideration of a company in crisis
  • Economic-financial and risk analysis
  • Economic-financial analysis of the project
  • Economic-financial adaptation of the company to the activities carried out by the project.

Deadline for submitting applications

The Cervera 2023 call for grants will remain open throughout the year.